Sign in

CIK 0001759425

  • Large accelerated filer

Mirum Pharmaceuticals, Inc.

Sign in to watch
Ticker
MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831281555
Phone
+1 650-667-4085
Business address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
  1. 4 Open-market sale CHIEF DEVELOPMENT OFFICER sold 1,003 shares at $20.62 ($20,684)
  2. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 5,159 shares at $20.62 ($106,390)
  3. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 2,000 shares at $25.80 ($51,600)
  4. 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 1,214 shares at $26.19 ($31,797)
  5. 4 Open-market sale CHIEF DEVELOPMENT OFFICER sold 847 shares at $26.19 ($22,184)
  6. 4 Open-market sale PRESIDENT AND COO sold 1,790 shares at $26.19 ($46,883)
  7. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 6,013 shares at $26.19 ($157,491)
  8. 4 Open-market sale SVP, GLOBAL CONTROLLER sold 735 shares at $26.19 ($19,251)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale CHIEF OPERATING OFFICER sold 1,408 shares at $28.03 ($39,473)
  18. 4 Open-market sale CHIEF DEVELOPMENT OFFICER sold 1,019 shares at $28.04 ($28,568)
  19. 4 Open-market sale HEAD OF RESEARCH & DEVELOPMENT sold 1,408 shares at $28.03 ($39,472)
  20. 4 Open-market sale PRESIDENT AND CEO sold 5,209 shares at $28.03 ($146,033)

Page 8 of 18 · 356 filings